Literature DB >> 11677086

Dendritic cells in autoimmune diseases.

B Ludewig1, T Junt, H Hengartner, R M Zinkernagel.   

Abstract

Subclinical autoimmune responses can be frequently detected in healthy individuals. Sustained activation of autoreactive lymphocytes is, however, required for the development of autoimmune diseases associated with ongoing tissue destruction either in single organs or generalized with multiple manifestations. Clinical and experimental evidence suggests that prolonged presentation of self antigens by dendritic cells is crucial for the development of destructive autoimmune disease. We discuss here a simplified threshold model where the key parameters for the magnitude of the autoimmune response are the amount of previously ignored self peptides presented by dendritic cells and the duration of the antigen presentation in secondary lymphoid organs. Multiple factors influence the threshold for the conversion of an autoimmune response to overt autoimmune disease. Frequent or persistent viral infections of the target organ may favor autoimmune disease by increasing the amounts of released self antigens, generating cytokine-mediated bystander activation of self-reactive lymphocytes and/or sustaining a chronic response via neoformation of lymphoid structures in the target organ.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11677086     DOI: 10.1016/s0952-7915(01)00275-8

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  20 in total

Review 1.  Dendritic cells and aging: consequences for autoimmunity.

Authors:  Anshu Agrawal; Aishwarya Sridharan; Sangeetha Prakash; Harsh Agrawal
Journal:  Expert Rev Clin Immunol       Date:  2012-01       Impact factor: 4.473

2.  Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-kappaB activation: potential role for the initiation of demyelinating disease.

Authors:  JoAnn P Palma; Daeho Kwon; Neil A Clipstone; Byung S Kim
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

3.  Direct B-cell stimulation by peripheral blood monocyte-derived dendritic cells in idiopathic thrombocytopenic purpura patients.

Authors:  Zhenhai Zhou; Xiaoyin Li; Juan Li; Chang Su; Lan Zhuang; Shaokai Luo; Ling Zhang
Journal:  J Clin Immunol       Date:  2010-07-14       Impact factor: 8.317

4.  An unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions.

Authors:  Zeyu Xiong; Enli Liu; Yan Yan; Richard T Silver; Fan Yang; Irene H Chen; Yangyang Chen; Srdan Verstovsek; Hong Wang; Josef Prchal; Xiao-Feng Yang
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

5.  A novel mechanism of alternative promoter and splicing regulates the epitope generation of tumor antigen CML66-L.

Authors:  Yan Yan; Leuyen Phan; Fan Yang; Moshe Talpaz; Yu Yang; Zeyu Xiong; Bernard Ng; Nikolai A Timchenko; Catherine J Wu; Jerome Ritz; Hong Wang; Xiao-Feng Yang
Journal:  J Immunol       Date:  2004-01-01       Impact factor: 5.422

6.  Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases.

Authors:  Bei Liu; Jie Dai; Hong Zheng; Diliana Stoilova; Shaoli Sun; Zihai Li
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

7.  Production of Heymann nephritis by a chemically modified renal antigen.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

8.  CML28 is a broadly immunogenic antigen, which is overexpressed in tumor cells.

Authors:  Xiao-Feng Yang; Catherine J Wu; Linyun Chen; Edwin P Alyea; Christine Canning; Philip Kantoff; Robert J Soiffer; Glenn Dranoff; Jerome Ritz
Journal:  Cancer Res       Date:  2002-10-01       Impact factor: 12.701

9.  Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis.

Authors:  Jian Rong Sheng; Liang Cheng Li; Balaji B Ganesh; Bellur S Prabhakar; Matthew N Meriggioli
Journal:  Clin Immunol       Date:  2008-05-27       Impact factor: 3.969

10.  Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.

Authors:  Arpad Z Barabas; Chad D Cole; Arpad D Barabas; Rene Lafreniere
Journal:  Biologics       Date:  2007-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.